newdrugapprovals.org
Pfizer’s PF 04937319 glucokinase activators for the treatment of Type 2 diabetes
PF 04937319 N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide MW 432.43 MF C22 H20 N6 O4 CAS …